feed,title,long_url,short_url
Benzinga,"Seres Therapeutics' SER-155 Reduces Infection, GvHD In Animal Study",https://benzinga.com/general/biotech/22/03/26200633/seres-therapeutics-ser-155-reduces-infection-gvhd-in-animal-study,https://bit.ly/3CSPt1G
Benzinga,"Protalix Bio, Chiesi Release Final Results From Late-Stage PRX-102 Trial In Fabry Disease",https://benzinga.com/general/biotech/22/03/26200480/protalix-bio-chiesi-release-final-results-from-late-stage-prx-102-trial-in-fabry-disease,https://bit.ly/3CPJPgR
Benzinga,Vickers Venture SPAC To Merge With Sorrento Therapeutics' Pain-Focused Subsidiary,https://benzinga.com/general/biotech/22/03/26199268/vickers-venture-spac-to-merge-with-sorrento-therapeutics-pain-focused-subsidiary,https://bit.ly/3ieMWFH
